Cyclooxygenase‐2 polymorphisms in Parkinson's diseasePlease cite this article as follows: Håkansson A, Bergman O, Chrapkowska C, Westberg L, Belin AC, Sydow O, Johnels B, Olson L, Holmberg B, Nissbrandt H. 2007. Cyclooxygenase‐2 Polymorphisms in Parkinson's Disease. Am J Med Genet Part B 144B:367–369.

Autor: Håkansson, Anna, Bergman, Olle, Chrapkowska, Cecilia, Westberg, Lars, Belin, Andrea Carmine, Sydow, Olof, Johnels, Bo, Olson, Lars, Holmberg, Björn, Nissbrandt, Hans

Publikováno v: American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics; April 2007, Vol. 144 Issue: 3 p367-369, 3p

Glucocerebrosidase variant T369M is not a risk factor for Parkinson's disease in Sweden.

Autor: Ran C; Department of Neuroscience, Karolinska Institutet, Solna, Sweden. Electronic address: caroline.ran@ki.se., Brodin L; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Gellhaar S; Department of Neuroscience, Karolinska Institutet, Solna, Sweden., Westerlund M; Department of Neuroscience, Karolinska Institutet, Solna, Sweden., Fardell C; Department of Pharmacology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Nissbrandt H; Department of Pharmacology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Söderkvist P; Faculty of Health Sciences, Division of Cell Biology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden., Sydow O; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Markaki I; Academic Specialist Center Torsplan, Stockholm, Sweden., Hertz E; Academic Specialist Center Torsplan, Stockholm, Sweden., Wirdefeldt K; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Svenningsson P; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Academic Specialist Center Torsplan, Stockholm, Sweden.

Publikováno v: Neuroscience letters [Neurosci Lett] 2022 Jul 27; Vol. 784, pp. 136767. Date of Electronic Publication: 2022 Jun 30.

Large-scale assessment of polyglutamine repeat expansions in Parkinson disease

Autor: Wang, L, Aasly, J, Annesi, G, Bardien, S, Bozi, M, Brice, A, Carr, J, Chung, S, Clarke, C, Crosiers, D, Deutschländer, A, Eckstein, G, Farrer, M, Goldwurm, S, Garraux, G, Hadjigeorgiou, G, Hicks, A, Hattori, N, Klein, C, Jeon, B, Kim, Y, Lesage, S, Lin, J, Lynch, T, Lichtner, P, Lang, A, Mok, V, Jasinska-Myga, B, Mellick, G, Morrison, K, Opala, G, Pihlstrøm, L, Pramstaller, P, Park, S, Quattrone, A, Rogaeva, E, Ross, O, Stefanis, L, Stockton, J, Silburn, P, Theuns, J, Tan, E, Tomiyama, H, Toft, M, Van Broeckhoven, C, Uitti, R, Wirdefeldt, K, Wszolek, Z, Xiromerisiou, G, Yueh, K, Zhao, Y, Gasser, T, Maraganore, D, Krüger, R, Sharma, M, Boyle, RS, Sellbach, A, O'Sullivan, JD, Sutherland, GT, Siebert, GA, Dissanayaka, NN, Pickut, B, Engelborghs, S, Meeus, B, De Deyn, PP, Cras, P, Lang, AE, Tzourio, C, Amouyel, P, Loriot, MA, Mutez, E, Duflot, A, Legendre, JP, Waucquier, N, Riess, O, Berg, D, Schulte, C, Djarmati, A, Hagenah, J, Lohman, K, Auburger, G, Hilker, R, van de Loo, S, Dardiotis, E, Tsimourtou, V, Ralli, S, Kountra, P, Patramani, G, Vogiatzi, C, Funayama, M, Yoshino, H, Li, Y, Imamichi, Y, Toda, T, Satake, W, Valente, EM, Ferraris, A, Dallapiccola, B, Ialongo, T, Brighina, L, Corradi, B, Ferrarese, C, Piolti, MR, Tarantino, P, Annesi, F, Gagliardi, M, Jeon, BS, Klodowska-Duda, G, Boczarska-Jedynak, M, Tan, EK, Belin, AC, Olson, L, Galter, D, Westerlund, M, Sydow, O, Nilsson, C, Puschmann, A, Lin, JJ, Maraganore, DM, Ahlskog, J, de Andrade, M, Lesnick, TG, Rocca, WA, Checkowa, H, Ross, OA, Wszolek, ZK, Uitti, RJ

Publikováno v: Neurology
Neurology (2015). doi:10.1212/WNL.0000000000002016
info:cnr-pdr/source/autori:Wang L1, Aasly JO1, Annesi G1, Bardien S1, Bozi M1, Brice A1, Carr J1, Chung SJ1, Clarke C1, Crosiers D1, Deutschländer A1, Eckstein G1, Farrer MJ1, Goldwurm S1, Garraux G1, Hadjigeorgiou GM1, Hicks AA1, Hattori N1, Klein C1, Jeon B1, Kim YJ1, Lesage S1, Lin JJ1, Lynch T1, Lichtner P1, Lang AE1, Mok V1, Jasinska-Myga B1, Mellick GD1, Morrison KE1, Opala G1, Pihlstrøm L1, Pramstaller PP1, Park SS1, Quattrone A1, Rogaeva E1, Ross OA1, Stefanis L1, Stockton JD1, Silburn PA1, Theuns J1, Tan EK1, Tomiyama H1, Toft M1, Van Broeckhoven C1, Uitti RJ1, Wirdefeldt K1, Wszolek Z1, Xiromerisiou G1, Yueh KC1, Zhao Y1, Gasser T1, Maraganore DM1, Krüger R1, Sharma M2; GEO-PD Consortium/titolo:Large-scale assessment of polyglutamine repeat expansions in Parkinson disease/doi:10.1212%2FWNL.0000000000002016/rivista:Neurology/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
ResearcherID

Objectives: We aim to clarify the pathogenic role of intermediate size repeat expansions of SCA2, SCA3, SCA6, and SCA17 as risk factors for idiopathic Parkinson disease (PD). Methods: We invited researchers from the Genetic Epidemiology of Parkinson9

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3b0fe39026c7bfeb5ea42ba83a45644
https://doi.org/10.1212/wnl.0000000000002016

Low prevalence of known pathogenic mutations in dominant PD genes: A Swedish multicenter study.

Autor: Puschmann A; Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Neurology, Lund, Sweden. Electronic address: Andreas.Puschmann@med.lu.se., Jiménez-Ferrer I; Lund University, Department of Experimental Medical Science, Lund, Sweden., Lundblad-Andersson E; Department of Clinical Genetics and Pathology, Division of Laboratory Medicine, Office for Medical Services, Region Skåne, Sweden., Mårtensson E; Department of Clinical Genetics and Pathology, Division of Laboratory Medicine, Office for Medical Services, Region Skåne, Sweden., Hansson O; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Sweden; Memory Clinic, Skåne University Hospital, Malmö, Sweden., Odin P; Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Neurology, Lund, Sweden., Widner H; Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Neurology, Lund, Sweden., Brolin K; Lund University, Department of Experimental Medical Science, Lund, Sweden., Mzezewa R; Lund University, Department of Experimental Medical Science, Lund, Sweden., Kristensen J; Department of Clinical Genetics and Pathology, Division of Laboratory Medicine, Office for Medical Services, Region Skåne, Sweden., Soller M; Department of Clinical Genetics and Pathology, Division of Laboratory Medicine, Office for Medical Services, Region Skåne, Sweden., Rödström EY; Lund University, Skåne University Hospital, Department of Clinical Sciences Lund, Neurology, Lund, Sweden., Ross OA; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA., Toft M; Department of Neurology, Oslo University Hospital, Oslo, Norway., Breedveld GJ; Erasmus MC, University Medical Center Rotterdam, Department of Clinical Genetics, Rotterdam, The Netherlands., Bonifati V; Erasmus MC, University Medical Center Rotterdam, Department of Clinical Genetics, Rotterdam, The Netherlands., Brodin L; Department of Clinical Neuroscience, Karolinska University Hospital, Stockholm, Sweden., Zettergren A; Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Sydow O; Department of Clinical Neuroscience, Karolinska University Hospital, Stockholm, Sweden., Linder J; Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden., Wirdefeldt K; Department of Clinical Neuroscience, Karolinska University Hospital, Stockholm, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Svenningsson P; Department of Clinical Neuroscience, Karolinska University Hospital, Stockholm, Sweden., Nissbrandt H; Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Belin AC; Department of Neuroscience, Karolinska Institutet, Solna, Sweden., Forsgren L; Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden., Swanberg M; Lund University, Department of Experimental Medical Science, Lund, Sweden.

Publikováno v: Parkinsonism & related disorders [Parkinsonism Relat Disord] 2019 Sep; Vol. 66, pp. 158-165. Date of Electronic Publication: 2019 Jul 31.

Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease.

Autor: Pålhagen, S. E., Dizdar, N., Hauge, T., Holmberg, B., Jansson, R., Linder, J., Nyholm, D., Sydow, O., Wainwright, M., Widner, H., Johansson, A.

Publikováno v: Acta Neurologica Scandinavica; Dec2012, Vol. 126 Issue 6, pe29-e33, 5p, 1 Diagram, 1 Chart, 1 Graph